We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05002569
Brief Title: A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma (RELATIVITY-098)

First Submitted : August 4, 2021
First Submitted that Met QC Criteria : August 4, 2021
First Posted : August 12, 2021

Last Update Submitted that Met QC Criteria : September 21, 2022
Last Update Posted : September 22, 2022